Michael S Hershfield

7PUBLICATIONS
87CO-AUTHORS
Gene and molecular therapyGene expression (incl. microarray and other genome-wide approaches)Infant and child healthDisease surveillanceMedical devices
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 22, 2026
A case of progressive multifocal leukoencephalopathy in an adult patient with ADA-SCID.

|Jun 18, 2026
ADA2 genotype and enzyme activity may predict vasculitic or hematologic DADA2 phenotype.

|May 22, 2026
Early identification of delayed-onset ADA deficiency: The case for expanded first-tier newborn screening.

|Mar 27, 2025
Multi-Year Registry Study of Elapegademase Treatment in Patients With Adenosine Deaminase Severe Combined Immunodeficiency (ADA-SCID) Requiring Enzyme Replacement Therapy.

Morna J Dorsey, Manish J Butte, Jay A Lieberman

|Apr 27, 2024
Treatment with Elapegademase Restores Immunity in Infants with Adenosine Deaminase Deficient Severe Combined Immunodeficiency.

Elizabeth Daly Hicks, Geoffrey Hall, Michael S Hershfield

|Jun 29, 2021
Normal IgH Repertoire Diversity in an Infant with ADA Deficiency After Gene Therapy.

Carolyn H Baloh, Samiksha A Borkar, Kai-Fen Chang

Pageof 2

Frequent Collaborators

5 joint publications

Teresa K Tarrant

2 joint publications

Talal Mousallem

2 joint publications

John W Sleasman

2 joint publications

Donald B Kohn